Incyte (INCY) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 78.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.25% |
| Dec 31, 2025 | 83.54% |
| Sep 30, 2025 | 88.25% |
| Jun 30, 2025 | 98.01% |
| Mar 31, 2025 | -41.97% |
| Dec 31, 2024 | -47.47% |
| Sep 30, 2024 | -59.59% |
| Jun 30, 2024 | -68.47% |
| Mar 31, 2024 | 18.62% |
| Dec 31, 2023 | 8.88% |
| Sep 30, 2023 | 19.94% |
| Jun 30, 2023 | 28.57% |
| Mar 31, 2023 | 25.00% |
| Dec 31, 2022 | 43.45% |
| Sep 30, 2022 | 34.60% |
| Jun 30, 2022 | 35.48% |
| Mar 31, 2022 | 35.14% |
| Dec 31, 2021 | 35.98% |
| Sep 30, 2021 | 33.47% |
| Jun 30, 2021 | 35.49% |
| Mar 31, 2021 | 60.07% |
| Dec 31, 2020 | -17.44% |
| Jun 30, 2020 | -6.32% |
| Mar 31, 2020 | -19.73% |
| Dec 31, 2019 | 57.45% |
| Jun 30, 2019 | 3,178.30% |
| Mar 31, 2019 | 2,385.09% |
| Dec 31, 2018 | 29.40% |
| Sep 30, 2018 | -1.41% |
| Jun 30, 2018 | -90.44% |
| Mar 31, 2018 | -85.55% |
| Dec 31, 2017 | 37.89% |
| Sep 30, 2017 | 94.46% |
| Jun 30, 2017 | -7.36% |
| Mar 31, 2017 | -44.98% |
| Dec 31, 2016 | 25.10% |
| Sep 30, 2016 | 30.13% |
| Jun 30, 2016 | 10.91% |
| Mar 31, 2016 | 55.90% |
| Dec 31, 2015 | 15.29% |
| Sep 30, 2015 | 16.70% |
| Jun 30, 2015 | 8.23% |
| Mar 31, 2015 | -3.38% |
| Dec 31, 2014 | -4.06% |
| Sep 30, 2014 | 40.38% |
| Jun 30, 2014 | 57.34% |
| Mar 31, 2014 | 64.24% |
| Dec 31, 2013 | 110.41% |
| Sep 30, 2013 | 13.82% |
| Jun 30, 2013 | 0.25% |
| Mar 31, 2013 | 14.65% |
| Dec 31, 2012 | -17.98% |
| Sep 30, 2012 | -23.45% |
| Jun 30, 2012 | -28.27% |
| Mar 31, 2012 | -38.64% |
| Dec 31, 2011 | -34.64% |
| Sep 30, 2011 | -19.67% |
| Jun 30, 2011 | -13.29% |
| Mar 31, 2011 | -6.65% |